• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液学患者中耐万古霉素肠球菌的分离

Isolation of vancomycin-resistant enterococci in haematologic patients.

作者信息

Guiot H F, Peetermans W E, Sebens F W

机构信息

Department of Infectious Diseases, University Hospital, Leiden, The Netherlands.

出版信息

Eur J Clin Microbiol Infect Dis. 1991 Jan;10(1):32-4. doi: 10.1007/BF01967094.

DOI:10.1007/BF01967094
PMID:2009875
Abstract

After the occurrence of septicaemia with a vancomycin-resistant Enterococcus faecalis strain in a patient, it was decided to determine the number of carriers of vancomycin-resistant cocci among haematologic patients. During a period of six months 135 stool samples from 25 children, and 400 samples from 70 adults were studied. All samples from the children were negative for vancomycin-resistant cocci. Nine of the adult patients had cultures positive for cocci, all identified as enterococci, which were highly resistant to vancomycin (MIC greater than 250 micrograms/ml), sensitive to amoxicillin, moderately resistant to gentamicin, slightly resistant to teicoplanin, and sensitive to daptomycin. None of these patients had been given vancomycin prior to the isolation of the vancomycin-resistant enterococci.

摘要

一名患者发生了由耐万古霉素粪肠球菌菌株引起的败血症后,决定测定血液学患者中耐万古霉素球菌携带者的数量。在六个月的时间里,研究了来自25名儿童的135份粪便样本和来自70名成人的400份样本。所有儿童样本中耐万古霉素球菌均为阴性。9名成年患者的球菌培养呈阳性,均鉴定为肠球菌,对万古霉素高度耐药(最低抑菌浓度大于250微克/毫升),对阿莫西林敏感,对庆大霉素中度耐药,对替考拉宁轻度耐药,对达托霉素敏感。在分离出耐万古霉素肠球菌之前,这些患者均未使用过万古霉素。

相似文献

1
Isolation of vancomycin-resistant enterococci in haematologic patients.血液学患者中耐万古霉素肠球菌的分离
Eur J Clin Microbiol Infect Dis. 1991 Jan;10(1):32-4. doi: 10.1007/BF01967094.
2
Vancomycin-resistant Enterococcus faecalis in a bone-marrow transplant recipient.
Scand J Infect Dis. 1991;23(1):105-9. doi: 10.3109/00365549109023382.
3
Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).亚太地区革兰氏阳性菌分离株的抗菌药敏性以及达托霉素、万古霉素和替考拉宁杀菌活性的体外评估:哨兵计划报告(2003 - 2004年)
Int J Antimicrob Agents. 2007 Aug;30(2):143-9. doi: 10.1016/j.ijantimicag.2007.03.015. Epub 2007 May 24.
4
Recovery of resistant enterococci during vancomycin prophylaxis.万古霉素预防期间耐万古霉素肠球菌的恢复情况。
J Clin Microbiol. 1988 Jun;26(6):1216-8. doi: 10.1128/jcm.26.6.1216-1218.1988.
5
[In vitro activity of vancomycin and teicoplanin against gram-positive cocci].[万古霉素和替考拉宁对革兰氏阳性球菌的体外活性]
Pathol Biol (Paris). 1992 May;40(5):461-5.
6
Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.多重耐药革兰氏阳性病原体。当前微生物学模式的最新情况。
Drugs. 1997;54 Suppl 6:11-20. doi: 10.2165/00003495-199700546-00005.
7
[The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].替考拉宁和万古霉素对革兰氏阳性微生物的体外活性(校正后)
Mikrobiyol Bul. 1991 Oct;25(4):321-5.
8
[Status and drug resistance surveillance of enterococcus infection in patients with severe hepatitis].[重型肝炎患者肠球菌感染的现状及耐药性监测]
Zhonghua Gan Zang Bing Za Zhi. 2006 May;14(5):375-7.
9
E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.粪肠球菌万古霉素敏感型肠球菌菌血症,对万古霉素耐受菌株无反应,经高剂量达托霉素成功治疗。
Heart Lung. 2007 Nov-Dec;36(6):456-61. doi: 10.1016/j.hrtlng.2007.02.012.
10
[Molecular characterization of vancomycin-resistant enterococci isolates].[耐万古霉素肠球菌分离株的分子特征]
Zhonghua Yi Xue Za Zhi. 2008 Mar 18;88(11):760-3.

引用本文的文献

1
Vancomycin-resistant enterococci (VRE) in hospital settings across European borders: a scoping review comparing the epidemiology in the Netherlands and Germany.跨越欧洲边界的医院环境中的万古霉素耐药肠球菌(VRE):一项比较荷兰和德国流行病学的范围综述。
Antimicrob Resist Infect Control. 2023 Aug 12;12(1):78. doi: 10.1186/s13756-023-01278-0.
2
Neonatal bacteremia due to high level aminoglycoside resistant (HLAR) enterococci.由高水平氨基糖苷类耐药肠球菌引起的新生儿菌血症。
Indian J Pediatr. 1997 Jul-Aug;64(4):537-9. doi: 10.1007/BF02737764.
3
Selective medium for screening for vancomycin-resistant enterococci in faeces.

本文引用的文献

1
Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study.急性非淋巴细胞白血病患者肠道菌群的选择性抗菌调节:一项双盲、安慰剂对照研究。
J Infect Dis. 1983 Apr;147(4):615-23. doi: 10.1093/infdis/147.4.615.
2
Selective antimicrobial modulation of the intestinal microbial flora for infection prevention in patients with hematologic malignancies. Evaluation of clinical efficacy and the value of surveillance cultures.选择性抗菌调节肠道微生物群以预防血液系统恶性肿瘤患者感染。临床疗效及监测培养价值的评估。
Scand J Infect Dis. 1986;18(2):153-60. doi: 10.3109/00365548609032322.
3
用于粪便中耐万古霉素肠球菌筛选的选择性培养基。
Eur J Clin Microbiol Infect Dis. 1996 Feb;15(2):175-7. doi: 10.1007/BF01591495.
4
Current perspectives on glycopeptide resistance.糖肽类耐药性的当前观点
Clin Microbiol Rev. 1995 Oct;8(4):585-615. doi: 10.1128/CMR.8.4.585.
5
Identification and characterization of multiple species of vancomycin-resistant enterococci, including an evaluation of Vitek software version 7.1.多种耐万古霉素肠球菌的鉴定与特性分析,包括对Vitek 7.1软件版本的评估
J Clin Microbiol. 1993 Oct;31(10):2777-9. doi: 10.1128/jcm.31.10.2777-2779.1993.
6
Prevalence of penicillin-resistant viridans streptococci in healthy children and in patients with malignant haematological disorders.
Eur J Clin Microbiol Infect Dis. 1994 Aug;13(8):645-50. doi: 10.1007/BF01973990.
7
Febrile neutropenic events in cancer patients: treatment for fever and neutropenia in young adult patients during intensive chemotherapy for solid tumours.癌症患者的发热性中性粒细胞减少事件:实体瘤强化化疗期间年轻成年患者发热和中性粒细胞减少的治疗
J Cancer Res Clin Oncol. 1992;118(5):395-9. doi: 10.1007/BF01294447.
8
New vancomycin disk diffusion breakpoints for enterococci. The National Committee for Clinical Laboratory Standards Working Group on Enterococci.肠球菌新的万古霉素纸片扩散法折点。美国国家临床实验室标准委员会肠球菌工作组
J Clin Microbiol. 1992 Oct;30(10):2525-8. doi: 10.1128/jcm.30.10.2525-2528.1992.
Side effects of intermediate- and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute leukaemia and non-Hodgkin's lymphoma.
中高剂量阿糖胞苷治疗难治性或复发性急性白血病及非霍奇金淋巴瘤的副作用
Neth J Med. 1987 Feb;30(1-2):64-74.
4
Comparison of physiologic tests used to identify non-beta-hemolytic aerococci, enterococci, and streptococci.用于鉴定非β-溶血气球菌、肠球菌和链球菌的生理学检测方法比较
J Clin Microbiol. 1987 Oct;25(10):1845-50. doi: 10.1128/jcm.25.10.1845-1850.1987.
5
Microbiological properties of teicoplanin.替考拉宁的微生物学特性。
J Antimicrob Chemother. 1988 Jan;21 Suppl A:1-13. doi: 10.1093/jac/21.suppl_a.1.
6
Prevention of bacteremia caused by alpha-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin.在接受环丙沙星治疗的粒细胞减少患者中,罗红霉素(RU-28965)对预防α溶血性链球菌引起的菌血症的作用
Infection. 1989 Jul-Aug;17(4):240-4. doi: 10.1007/BF01639528.
7
Identification of gram-positive coccal and coccobacillary vancomycin-resistant bacteria.革兰氏阳性球菌和球杆菌耐万古霉素细菌的鉴定。
J Clin Microbiol. 1989 Apr;27(4):724-30. doi: 10.1128/jcm.27.4.724-730.1989.
8
In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria.达托霉素及其他抗菌药物对耐万古霉素革兰氏阳性菌的体外活性
Antimicrob Agents Chemother. 1989 Aug;33(8):1383-4. doi: 10.1128/AAC.33.8.1383.
9
Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis.粪肠球菌和屎肠球菌中万古霉素耐药性的特征分析
Antimicrob Agents Chemother. 1989 Jul;33(7):1121-4. doi: 10.1128/AAC.33.7.1121.
10
Transferable vancomycin and teicoplanin resistance in Enterococcus faecium.粪肠球菌中可转移的万古霉素和替考拉宁耐药性
Antimicrob Agents Chemother. 1989 Jan;33(1):10-5. doi: 10.1128/AAC.33.1.10.